The FY2025 (Dec) proxy of Mirum Pharmaceuticals names 21 peer companies for pay. Among Mirum Pharmaceuticals and these peers, CEO pay was 5th highest of 7 and total shareholder return was the highest of 7.
5th highest of 7in Mirum Pharmaceuticals and its pay peers, FY2025 (Dec) by CEO pay:
$5.4M$15.5M
1st highest of 7in Mirum Pharmaceuticals and its pay peers, FY2025 (Dec) by total shareholder return:
$17$495
Pay peer group, FY2025 (Dec) proxy
| Supernus Pharmaceuticals | ||
| BridgeBio Pharma | ||
| Cytokinetics | ||
| Ultragenyx Pharmaceutical | ||
| Travere Therapeutics | ||
| Agios Pharmaceuticals | ||
| Acadia Pharmaceuticals | Not disclosed | Not disclosed |
| Amicus Therapeutics | Not disclosed | Not disclosed |
| Ardelyx | Not disclosed | Not disclosed |
| Biocryst Pharmaceuticals | Not disclosed | Not disclosed |
| Blueprint Medicines | Not disclosed | Not disclosed |
| Catalyst Pharmaceuticals | Not disclosed | Not disclosed |
| Collegium Pharmaceuticals | Not disclosed | Not disclosed |
| Corcept Therapeutics | Not disclosed | Not disclosed |
| Crinetics Pharmaceuticals | Not disclosed | Not disclosed |
| Dynavax Technologies | Not disclosed | Not disclosed |
| Ironwood Pharmaceuticals | Not disclosed | Not disclosed |
| Mannkind | Not disclosed | Not disclosed |
| Rhythm Pharmaceuticals | Not disclosed | Not disclosed |
| Syndax Pharmaceuticals | Not disclosed | Not disclosed |
| Vericel | Not disclosed | Not disclosed |
21 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.